Literature DB >> 25424491

Determinants of medication non-adherence in Egyptian patients with systemic lupus erythematosus: Sharkia Governorate.

Amal B Abdul-Sattar1, Sahar A Abou El Magd.   

Abstract

The aim of the study was to identify the determinants of adherence to medication among Egyptian patients with SLE. A single-center cross-sectional study was conducted among Egyptian patients with SLE. Adherence to medication was measured via The Compliance Questionnaire for Rheumatology-19, and the patients were classified as non-adherers if they were taking <80% of their medication correctly. Predictors of adherence to SLE medication were determined by multiple logistic regressions. The mean age of participants was 30.9 ± 11.7 years. Females constituted 95% of all participants. Thirty-eight (%) were taking <80% of their medication correctly. On logistic regression analysis, the significant independent predictors of medication non-adherence were lower educational level (OR 5.6, 95% CI 2.1-7.3, P < 0.001), very low and low socioeconomic status (OR 2.6, 95% CI 1.6-4.3, P < 0.04), rural residency (OR 3.4, 95% CI 1.4-5, P < 0.01), more number of medications (OR 3.2, 95% CI 2.3-6.9, P < 0.01), and higher depressive symptoms (OR 3.7, 95% CI 1.4-10.2, P < 0.001). The adherence rate reported in this study was quite low. Appropriate adherence enhancing intervention strategies targeted at reducing pill load, minimizing depressive symptoms, and ensuring an uninterrupted access to free services regimen for patients with low socioeconomic status is strongly recommended. More attention should be given to SLE patients who live in rural regions.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25424491     DOI: 10.1007/s00296-014-3182-0

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  43 in total

1.  Inadequate therapy behavior is associated to disease flares in patients with rheumatoid arthritis who have achieved remission with disease-modifying antirheumatic drugs.

Authors:  Irazú Contreras-Yáñez; Sergio Ponce De León; Javier Cabiedes; Marina Rull-Gabayet; Virginia Pascual-Ramos
Journal:  Am J Med Sci       Date:  2010-10       Impact factor: 2.378

2.  'Compliance' is futile but is 'concordance' between rheumatology patients and health professionals attainable?

Authors:  G J Treharne; A C Lyons; E D Hale; K M J Douglas; G D Kitas
Journal:  Rheumatology (Oxford)       Date:  2006-01       Impact factor: 7.580

3.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

4.  Factors affecting drug treatment compliance in patients with rheumatoid arthritis.

Authors:  Reyhan Tuncay; Emel Eksioglu; Banu Cakir; Eda Gurcay; Aytul Cakci
Journal:  Rheumatol Int       Date:  2007-01-11       Impact factor: 2.631

5.  The performance of the Center for Epidemiologic Study Depression Scale (CES-D) in an Arab female community.

Authors:  R Ghubash; T K Daradkeh; K S Al Naseri; N B Al Bloushi; A M Al Daheri
Journal:  Int J Soc Psychiatry       Date:  2000

6.  Factors influencing the beliefs of patients with rheumatoid arthritis regarding disease-modifying medication.

Authors:  L J Goodacre; J A Goodacre
Journal:  Rheumatology (Oxford)       Date:  2004-02-17       Impact factor: 7.580

Review 7.  Understanding the epidemiology and progression of systemic lupus erythematosus.

Authors:  Guillermo J Pons-Estel; Graciela S Alarcón; Lacie Scofield; Leslie Reinlib; Glinda S Cooper
Journal:  Semin Arthritis Rheum       Date:  2009-01-10       Impact factor: 5.532

8.  Why do patients with systemic lupus erythematosus take or fail to take their prescribed medications? A qualitative study in a UK cohort.

Authors:  S A Chambers; R Raine; A Rahman; D Isenberg
Journal:  Rheumatology (Oxford)       Date:  2009-01-16       Impact factor: 7.580

9.  Missed medication doses in rheumatic arthritis patients: intentional and unintentional reasons.

Authors:  C D Lorish; B Richards; S Brown
Journal:  Arthritis Care Res       Date:  1989-03

10.  The funding and use of high-cost medicines in Australia: the example of anti-rheumatic biological medicines.

Authors:  Christine Y Lu; Kenneth M Williams; Richard O Day
Journal:  Aust New Zealand Health Policy       Date:  2007-03-01
View more
  10 in total

1.  Depression and medication nonadherence in childhood-onset systemic lupus erythematosus.

Authors:  A M Davis; T B Graham; Y Zhu; M L McPheeters
Journal:  Lupus       Date:  2018-06-28       Impact factor: 2.911

Review 2.  Rheumatology in Egypt: back to the future.

Authors:  Tamer A Gheita; Nahla N Eesa
Journal:  Rheumatol Int       Date:  2018-11-07       Impact factor: 2.631

Review 3.  The Duality of Economic Issues With Medication Non-adherence in Patients With Inflammatory Arthritis.

Authors:  Natasha K J Campbell; Khalid Saadeldin; Mary A De Vera
Journal:  Curr Rheumatol Rep       Date:  2017-09-18       Impact factor: 4.592

4.  The rate of adherence to urate-lowering therapy and associated factors in Chinese gout patients: a cross-sectional study.

Authors:  Rulan Yin; Haixia Cao; Ting Fu; Qiuxiang Zhang; Lijuan Zhang; Liren Li; Zhifeng Gu
Journal:  Rheumatol Int       Date:  2017-05-27       Impact factor: 2.631

Review 5.  A systematic review of the barriers affecting medication adherence in patients with rheumatic diseases.

Authors:  Hendra Goh; Yu Heng Kwan; Yi Seah; Lian Leng Low; Warren Fong; Julian Thumboo
Journal:  Rheumatol Int       Date:  2017-07-05       Impact factor: 2.631

6.  Adherence to Oral and Topical Medications in Cutaneous Lupus Erythematosus is not Well Characterized.

Authors:  Michael E Farhangian; William W Huang; Steven R Feldman
Journal:  Dermatol Ther (Heidelb)       Date:  2015-04-22

7.  Predictors of medication nonadherence in patients with systemic lupus erythematosus in Sichuan: a cross-sectional study.

Authors:  Xia Xie; Hui Yang; Anliu Nie; Hong Chen; Jiping Li
Journal:  Patient Prefer Adherence       Date:  2018-08-21       Impact factor: 2.711

8.  How Can We Enhance Adherence to Medications in Patients with Systemic Lupus Erythematosus? Results from a Qualitative Study.

Authors:  Sharzad Emamikia; Cidem Gentline; Yvonne Enman; Ioannis Parodis
Journal:  J Clin Med       Date:  2022-03-27       Impact factor: 4.241

Review 9.  Medication Non-Adherence in Rheumatology, Oncology and Cardiology: A Review of the Literature of Risk Factors and Potential Interventions.

Authors:  Vicente F Gil-Guillen; Alejandro Balsa; Beatriz Bernárdez; Carmen Valdés Y Llorca; Emilio Márquez-Contreras; Juan de la Haba-Rodríguez; Jose M Castellano; Jesús Gómez-Martínez
Journal:  Int J Environ Res Public Health       Date:  2022-09-23       Impact factor: 4.614

Review 10.  Medication adherence and persistence in patients with autoimmune rheumatic diseases: a narrative review.

Authors:  Laura-Alexandra Anghel; Andreea Maria Farcaş; Radu Nicolae Oprean
Journal:  Patient Prefer Adherence       Date:  2018-07-03       Impact factor: 2.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.